194 related articles for article (PubMed ID: 27751763)
21. Measurement of heparin concentration in whole blood with the Hepcon/HMS device does not agree with laboratory determination of plasma heparin concentration using a chromogenic substrate for activated factor X.
Hardy JF; Bélisle S; Robitaille D; Perrault J; Roy M; Gagnon L
J Thorac Cardiovasc Surg; 1996 Jul; 112(1):154-61. PubMed ID: 8691862
[TBL] [Abstract][Full Text] [Related]
22. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
[TBL] [Abstract][Full Text] [Related]
23. Management of a Patient With Antiphospholipid Syndrome Undergoing Aortic Valve Replacement Using the Hepcon Hemostasis Management System Plus and Rotational Thromboelastometry: A Case Report.
Samejima Y; Kodaka M; Ichikawa J; Mori T; Ando K; Nishiyama K; Komori M
A A Case Rep; 2017 Mar; 8(5):100-104. PubMed ID: 28098662
[TBL] [Abstract][Full Text] [Related]
24. Activated clotting time for control of anticoagulation during surgery.
Lefemine AA; Lewis M
Am Surg; 1985 May; 51(5):274-8. PubMed ID: 3994170
[TBL] [Abstract][Full Text] [Related]
25. The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass: a pilot investigation.
Koster A; Despotis G; Gruendel M; Fischer T; Praus M; Kuppe H; Levy JH
Anesth Analg; 2002 Jul; 95(1):26-30, table of contents. PubMed ID: 12088937
[TBL] [Abstract][Full Text] [Related]
26. Response to heparinization in adults and children undergoing cardiac operations.
Horkay F; Martin P; Rajah SM; Walker DR
Ann Thorac Surg; 1992 May; 53(5):822-6. PubMed ID: 1570978
[TBL] [Abstract][Full Text] [Related]
27. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
[TBL] [Abstract][Full Text] [Related]
28. Heparin and Protamine Titration Does Not Improve Haemostasis after Cardiac Surgery: A Prospective Randomized Study.
Radulovic V; Laffin A; Hansson KM; Backlund E; Baghaei F; Jeppsson A
PLoS One; 2015; 10(7):e0130271. PubMed ID: 26134993
[TBL] [Abstract][Full Text] [Related]
29. Anticoagulation monitoring during extracorporeal circulation with the Hepcon/HMS device.
Noui N; Zogheib E; Walczak K; Werbrouck A; Amar AB; Dupont H; Caus T; Remadi JP
Perfusion; 2012 May; 27(3):214-20. PubMed ID: 22301392
[TBL] [Abstract][Full Text] [Related]
30. In Vivo Protamine Titration Using Activated Coagulation Time to Neutralize Heparin Anticoagulation in Cardiac Surgery: Proof of Concept.
Rochon AG; Bélisle S; Couture P; Fortier A; Lebon JS; Deschamps A
J Cardiothorac Vasc Anesth; 2020 Sep; 34(9):2369-2374. PubMed ID: 32014311
[TBL] [Abstract][Full Text] [Related]
31. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph.
Khan NU; Wayne CK; Barker J; Strang T
Eur J Anaesthesiol; 2010 Jul; 27(7):624-7. PubMed ID: 20485179
[TBL] [Abstract][Full Text] [Related]
32. Heparin monitoring during cardiopulmonary bypass.
Saleem A; Shenaq SS; Yawn DH; Harshberger K; Diemunsch P; Mohindra P
Ann Clin Lab Sci; 1984; 14(6):474-9. PubMed ID: 6508227
[TBL] [Abstract][Full Text] [Related]
33. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a new point of care heparin test for cardiopulmonary bypass: the TAS heparin management test.
Wallock M; Jeske WP; Bakhos M; Walenga JM
Perfusion; 2001 Mar; 16(2):147-53. PubMed ID: 11334198
[TBL] [Abstract][Full Text] [Related]
35. Anticoagulation management in patients undergoing open heart surgery by activated clotting time and whole blood heparin concentration.
Pappalardo F; Franco A; Crescenzi G; De Simone F; Torracca L; Zangrillo A
Perfusion; 2006 Dec; 21(5):285-90. PubMed ID: 17201083
[TBL] [Abstract][Full Text] [Related]
36. An Adjusted Calculation Model of Reduced Heparin Doses in Cardiopulmonary Bypass Surgery in a Chinese Population.
Zhang Y; Liu K; Li W; Xue Q; Hong J; Xu J; Wu L; Ji G; Sheng J; Wang Z
J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1179-83. PubMed ID: 27475733
[TBL] [Abstract][Full Text] [Related]
37. Age-related differences in heparin sensitivity and heparin-protamine interactions in cardiac surgery patients.
D'Errico C; Shayevitz JR; Martindale SJ
J Cardiothorac Vasc Anesth; 1996 Jun; 10(4):451-7. PubMed ID: 8776636
[TBL] [Abstract][Full Text] [Related]
38. Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass.
Teoh KH; Young E; Bradley CA; Hirsh J
Circulation; 1993 Nov; 88(5 Pt 2):II420-5. PubMed ID: 8222188
[TBL] [Abstract][Full Text] [Related]
39. Changes in heparin dose response slope during cardiac surgery: possible result in inaccuracy in predicting heparin bolus dose requirement to achieve target ACT.
Ichikawa J; Mori T; Kodaka M; Nishiyama K; Ozaki M; Komori M
Perfusion; 2017 Sep; 32(6):474-480. PubMed ID: 28820035
[TBL] [Abstract][Full Text] [Related]
40. Thromboprophylaxis With Heparin During Orthotopic Liver Transplantation: Comparison of Hepcon HMS Plus and Anti-Xa Assays for Low-Range Heparin.
Nicolau-Raducu R; Occhipinti E; Marshall T; Koveleskie J; Ganier D; Evans B; Daly W; Fish B; Cohen AJ; Reichman TW; Bruce D; Bohorquez H; Seal J; Ahmed E; Carmody I; Loss G; Rayburn J; Nossaman B
J Cardiothorac Vasc Anesth; 2017 Apr; 31(2):575-581. PubMed ID: 27745797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
